Welcome to the Department of Urology
Our department is committed to excellence and improving everything we do. From our innovative patient care, to our highest caliber education program, and cutting-edge research, we work together to turn discoveries into reality and improve the lives of our patients.
Department News & Highlights
Welcome new faculty Dr. Jay Shah!
We are so excited to have welcomed new faculty member Dr. Jay Shah to our department earlier this year. Dr. Shah joins us from MD Anderson Cancer Center, where he served as Medical Director of the Genitourinary Center, Director of the Badder Cancer Robotics Program, as well as the supervisor of Medical Student Education in the Department of Urology.
Open Faculty Positions
This Department of Urology is seeking qualified faculty for several open positions to join its distinguished group of medical professionals.
Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns
Timing of adverse prostate cancer reclassification on first surveillance biopsy: results from the Canary prostate cancer active surveillance study
Defining the rate of negative ureteroscopy in the general population treated for upper tract urinary stone disease
3D reconstruction of cystoscopy videos for comprehensive bladder records
Oncologic procedures amenable to fluorescence-guided surgery
New article shows that there are extensive chemical modifications to the DNA of prostate cancers called DNA methylation
The changes are known to affect gene regulation, and we find that genes regulated by a specific protein, called EZH2, are particularly targeted by this chemical modification. Furthermore, these methylation changes, since they are specific for prostate cancer, could form the basis of new tools to diagnose prostate cancer.
In a large study covering 10 institutions across the country, over 1400 men were enrolled with relatively low risk prostate cancer, and watched with PSA testing and periodic biopsies. The study reports that men who are obese have a higher risk for showing more cancer or higher grade cancer when they are biopsied after 1 year of surveillance. Likewise, men who have a relatively small prostate and high PSA (high PSA density) also have a higher risk. These men might need to undergo biopsy sooner when on active surveillance. See article highlight in the accompanying editorial in the Journal of Urology.
Dr. Jim Brooks helped author the article, The Radiogenomic Risk Score: Construction of a Prognostic Quantitative, Noninvasive Image-based Molecular Assay for Renal Cell Carcinoma, which won the 2016 Margulis Award for Scientific Excellence awarded by the Radiological Society of North America earlier this year.
Recent publication "Defining the rate of negative ureteroscopy in the general population treated for upper tract urinary stone disease" featured in Uro Today: Beyond the Abstract.
Dr. Michael Eisenberg, who specializes in male fertility, says men are underserved when it comes to infertility testing, partly because it's "incorrectly seen as a woman's problem." In 20 to 25 percent of infertility cases, men aren't even evaluated. That could change, Eisenberg said, with home-based testing that made it easier and less anxiety-inducing to analyze a sperm sample.
Congratulations 2017 Norcal Winners!
"Racial Disparities in Hospital Admissions in the First 30 Days After Urethral Sling Procedures in California"
"IQGAP1 Scaffold-Kinase Interaction Blockade in Renal Cell Carcinoma: A Novel Biomarker and Therapeutic Strategy"
"Automated and Dynamic Classification of Bladder Cancer Using Deep Learning on Real-Time Confocal Laser Endomicroscopy Images"